(1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)-1H-indol-2-yl)boronic acid, 95.0%, 100mg

(S)-Piperidine-2-carboxylic acid hydrochloride, 95.0%, 5g

(1-(Ethoxycarbonyl)cyclopropyl)triphenylphosphonium tetrafluoroborate, 97%, 100mg

2,3-Dihydroxybenzoic Acid>98.0%(HPLC)(T)5g

ethyl 1-(2-cyano-4-nitrophenyl)piperidine-3-carboxylate, 250mg

Nicotinimidamide, 98+%, 25g

Benzonitrile, 4-[2-(2-cyclopentylidenehydrazinyl)-4-thiazolyl]-, hydrobromide (1:1), 50mg

Octahydroisoindole, 95.0%, 5g

1,2-Propanediol, min 99.5%, for synthesis, 25 l, plastic packaging.

N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine-1-carboxamide, 98%, 1g

(1-Methoxypropan-2-yl)urea, 95%, 250mg

Methyl 2-amino-5-isopropylthiazole-4-carboxylate, 95.0%, 1g

3-Chloroacetylacetone>95.0%(GC)25g